Ultrasound is a front-line diagnostic and monitoring tool for patients with COVID-19.
In caring for patients with COVID-19, ultrasound can be used for lung ultrasound, transthoracic echocardiography, and ultrasound-guided thoracentesis and vascular access.
Through clinical use, ultrasound probes may become contaminated with pathogens including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19.
Due to the recent emergence of the virus, trophon2 has not been tested directly against SARS-CoV-2. However, SARS-CoV-2 is an enveloped virus and trophon2 is effective against both enveloped and non-enveloped viruses.1-3
Having a reprocessing solution that is proven effective against a broad range of pathogens, including the inactivation of enveloped viruses such as SARS-CoV-2, is a key to your infection prevention efforts.
With more than 22,000 units installed in over 7,000 hospitals in the U.S and around the world, trophon is the standard of care in the U.S and around the world. It is a fully enclosed automated high level disinfection solution that uses sonicated hydrogen peroxide technology to disinfect ultrasound probes.
trophon2 – helps protect you and your patients from the risk of cross-contamination.
- FDA 2000. Guidance for Industry and FDA Reviewers: Content and Format of Premarket Notification [510(k)] Submissions for Liquid Chemical Sterilants/High Level Disinfectants.
- Vickery K, et al. Evaluation of an automated high-level disinfection technology for ultrasound transducers. J Infect Public Health 2014;7(2):153-60.
- trophon Microbial efficacy. Available at: https://www.nanosonics.us/clinical/microbial-efficacy/